Petra Buttner
Overview
Explore the profile of Petra Buttner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
121
Citations
1633
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Buttner P, Augstein A, Abdellatif M, Lourenco A, Leite-Moreira A, Falcao-Pires I, et al.
ESC Heart Fail
. 2024 Dec;
PMID: 39663741
Aims: ZSF1 obese rats harbouring two mutant leptin receptor alleles (Lepr and Lepr) develop metabolic syndrome and heart failure with preserved ejection fraction (HFpEF), making them a widely used animal...
2.
Kogel A, Baumann L, Maeder C, Buttner P, Thiele H, Kneuer J, et al.
Am J Physiol Heart Circ Physiol
. 2024 Aug;
327(4):H869-H879.
PMID: 39178030
Cardiogenic shock (CS) is characterized by impaired cardiac function, very high mortality, and limited treatment options. The proinflammatory signaling during different phases of CS is incompletely understood. We collected serum...
3.
Guivala S, Bode K, Okun J, Kartal E, Schwedhelm E, Pohl L, et al.
Cardiovasc Diabetol
. 2024 Aug;
23(1):299.
PMID: 39143579
Background: Heart failure with preserved ejection fraction (HFpEF) is associated with systemic inflammation, obesity, metabolic syndrome, and gut microbiome changes. Increased trimethylamine-N-oxide (TMAO) levels are predictive for mortality in HFpEF....
4.
Cheng W, Maciej R, Thiele H, Buttner P
ESC Heart Fail
. 2024 May;
11(5):2566-2577.
PMID: 38698741
Aims: This meta-analysis investigated the dose-response relationship between circulating galectin-3 levels and adverse outcomes in patients with heart failure (HF). Methods And Results: PubMed and Embase were screened for studies...
5.
Bottner J, Fischer-Schaepmann T, Werner S, Knauth S, Jahnke H, Thiele H, et al.
Sci Rep
. 2024 Feb;
14(1):3596.
PMID: 38351286
Abuse of amphetamine-type stimulants is linked to cardiovascular adverse effects like arrhythmias, accelerated atherosclerosis, acute coronary syndromes and sudden cardiac death. Excessive catecholamine release following amphetamine use causes vasoconstriction and...
6.
Obradovic D, Loncar G, Zeymer U, Poss J, Feistritzer H, Freund A, et al.
Eur J Heart Fail
. 2023 Dec;
26(2):448-457.
PMID: 38084483
Aims: Anaemia and iron deficiency (ID) are common comorbidities in cardiovascular patients and are associated with a poor clinical status, as well as a worse outcome in patients with heart...
7.
Schwarzkopf L, Buttner P, Scholtyssek K, Schroter T, Hiller R, Hindricks G, et al.
Heliyon
. 2023 Nov;
9(11):e21268.
PMID: 37954289
Background: Subpopulations of myocardial c-kit cells have the ability to stimulate regeneration in ischemic heart disease by paracrine effects. The left atrial appendage (LAA), which is easy accessible during cardiac...
8.
Feistner L, Penk A, Bottner J, Buttner P, Thiele H, Huster D, et al.
Sci Rep
. 2023 Nov;
13(1):18823.
PMID: 37914797
Fibro-calcific aortic valve disease (FCAVD) is a pathological condition marked by overt fibrous and calcific extracellular matrix (ECM) accumulation that leads to valvular dysfunction and left ventricular outflow obstruction. Costly...
9.
Buttner P, Werner S, Bottner J, Ossmann S, Schwedhelm E, Thiele H
Int J Mol Sci
. 2023 Oct;
24(19).
PMID: 37834229
A restoration of low homoarginine (hArg) levels in obese ZSF1 rats (O-ZSF1) before (S1-ZSF1) and after (S2-ZSF1) the manifestation of heart failure with preserved ejection fraction (HFpEF) did not affect...
10.
Poss J, Buttner P, Thiele H
Eur Heart J
. 2023 Aug;
44(38):3872-3874.
PMID: 37632844
No abstract available.